– Report will be subject of public meeting of California Technology Assessment Forum (CTAF) on July 11, 2014 –

San Francisco, Calif., June 13, 2014 – The Institute for Clinical and Economic Review (ICER) has posted the draft report “Controversies in Migraine Management” for public comment. This report will be the subject of deliberation and vote at the next public meeting of the California Technology Assessment Forum (CTAF) on Friday, July 11 in Los Angeles, California. This report aims to help the members of CTAF and the public understand the latest evidence on the relative effectiveness and value of four different treatment options for individuals suffering from migraine headaches. The report examines two newly approved devices for the management of migraine (a transcutaneous electrical nerve stimulation device named Cefaly and a transcranial magnetic stimulation device named SpringTMS), as well as two more established drug therapies (Botox injections for the prevention of chronic migraines and the use of opioids for acute treatment of migraines in the emergency department). The report will be available for public comment until 5:00 PM PT, Thursday, July 3, 2014.

Meeting Details

Date: Friday, July 11, 2014

Time: 10:00 AM – 4:00 PM PT

Location: Sheraton Gateway Hotel at LAX

6101 West Century Boulevard

Los Angeles, CA 90045

Members of the public wishing to attend the meeting should register by July 3, 2014 by clicking here. The CTAF website also includes instructions for those wishing to submit written comments prior to the meeting. Members of the public wishing to deliver an oral comment during the public meeting must email ctaf@icer-review.org by 5:00 PM PT Monday, July 7, 2014. Availability of time slots for public comments is limited.

An audio recording of the July 11, 2014 meeting will be made available on the CTAF website following the meeting for members of the public unable to attend in-person.

About CTAF

The California Technology Assessment Forum (CTAF) – a core program of the Institute for Clinical and Economic Review (ICER) – reviews objective evidence reports and holds public meetings to develop recommendations for how patients, clinicians, insurers, and policymakers can improve the quality and value of health care.  For more information about CTAF, please visit www.ctaf.org.

About ICER

The Institute for Clinical and Economic Review (ICER) is an independent non-profit health care research organization dedicated to improving the interpretation and application of evidence in the health care system.  ICER directs two core programs: CTAF, and the New England Comparative Effectiveness Public Advisory Council (CEPAC).  For more information about ICER, please visit ICER’s website, www.icer-review.org.

# # #